Insulin enhances the effect of nitric oxide at inhibiting neointimal hyperplasia in a rat model of type 1 diabetes
Authors:
- 1 September 2010
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 299 (3) , H772-H779
Abstract
Diabetes confers greater restenosis from neointimal hyperplasia following vascular interventions. While localized administration of nitric oxide (NO) is known to inhibit neointimal hyperplasia, the effect of NO in type 1 diabetes is unknown. Thus the aim of this study was to determine the efficacy of NO following arterial injury, with and without exogenous insulin administration. Vascular smooth muscle cells (VSMC) from lean Zucker (LZ) rats were exposed to the NO donor, DETA/NO, following treatment with different glucose and/or insulin concentrations. DETA/NO inhibited VSMC proliferation in a concentration-dependent manner to a greater extent in VSMC exposed to normal-glucose vs. high-glucose environments, and even more effectively in normal-glucose/high-insulin and high-glucose/high-insulin environments. G0/G1 cell cycle arrest and cell death were not responsible for the enhanced efficacy of NO in these environments. Next, type 1 diabetes was induced in LZ rats with streptozotocin. The rat carotid artery injury model was performed. Type 1 diabetic rats experienced no significant reduction in neointimal hyperplasia following arterial injury and treatment with the NO donor PROLI/NO. However, daily administration of insulin to type 1 diabetic rats restored the efficacy of NO at inhibiting neointimal hyperplasia (60% reduction, P < 0.05). In conclusion, these data demonstrate that NO is ineffective at inhibiting neointimal hyperplasia in an uncontrolled rat model of type 1 diabetes; however, insulin administration restores the efficacy of NO at inhibiting neointimal hyperplasia. Thus insulin may play a role in regulating the downstream beneficial effects of NO in the vasculature.Keywords
This publication has 48 references indexed in Scilit:
- Heightened efficacy of nitric oxide-based therapies in type II diabetes mellitus and metabolic syndromeAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- Chronic insulin treatment amplifies PDGF-induced motility in differentiated aortic smooth muscle cells by suppressing the expression and function of PTP1BAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- Oxidative stress and vascular disease in diabetes: Is the dichotomization of insulin signaling still valid?Free Radical Biology and Medicine, 2008
- Nitric oxide and nanotechnology: A novel approach to inhibit neointimal hyperplasiaJournal of Vascular Surgery, 2008
- Beneficial effect of a short-acting NO donor for the prevention of neointimal hyperplasiaFree Radical Biology and Medicine, 2008
- Impact of diabetes mellitus on outcomes of superficial femoral artery endoluminal interventionsJournal of Vascular Surgery, 2007
- Nitric oxide–releasing biopolymers inhibit thrombus formation in a sheep model of arteriovenous bridge graftsJournal of Vascular Surgery, 2004
- Hyperglycemia enhances VSMC proliferation with NF-κB activation by angiotensin II and E2F-1 augmentation by growth factorsMolecular and Cellular Endocrinology, 2002
- Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P.Journal of Clinical Investigation, 1994
- NITRIC OXIDE: A Physiologic Messenger MoleculeAnnual Review of Biochemistry, 1994